PLx Pharma Winddown Corp.

2017 Q3 Form 10-Q Financial Statement

#000143774917018920 Filed on November 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q4 2016 Q3

Balance Sheet

Concept 2017 Q3 2016 Q4 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.44M $60.00K $18.83M
YoY Change 61.66% -99.81% -47.94%
Cash & Equivalents $30.44M $59.34K $187.4K
Short-Term Investments $11.00M
Other Short-Term Assets $590.0K $0.00 $170.0K
YoY Change 247.06% -100.0% 13.33%
Inventory $372.5K $116.7K
Prepaid Expenses $336.7K $4.652K
Receivables $60.00K $10.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $31.46M $189.9K $19.00M
YoY Change 65.56% -99.41% -47.7%
LONG-TERM ASSETS
Property, Plant & Equipment $902.4K $426.6K
YoY Change
Goodwill $2.061M
YoY Change
Intangibles $2.296M $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $60.00K $56.63K $60.00K
YoY Change 0.0% 14.67% 20.0%
Total Long-Term Assets $5.316M $426.6K $60.00K
YoY Change 8760.75% 763.89% 20.0%
TOTAL ASSETS
Total Short-Term Assets $31.46M $189.9K $19.00M
Total Long-Term Assets $5.316M $426.6K $60.00K
Total Assets $36.77M $616.5K $19.06M
YoY Change 92.93% -98.1% -47.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.050M $860.0K $30.00K
YoY Change 3400.0% 2766.67% 200.0%
Accrued Expenses $2.460M $100.0K $860.0K
YoY Change 186.05% -93.67% 7.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.780M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.506M $2.736M $890.0K
YoY Change 293.93% 69.93% 9.88%
LONG-TERM LIABILITIES
Long-Term Debt $6.868M $0.00
YoY Change
Other Long-Term Liabilities $14.18M
YoY Change
Total Long-Term Liabilities $6.868M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.506M $2.736M $890.0K
Total Long-Term Liabilities $6.868M $0.00 $0.00
Total Liabilities $24.56M $2.936M $890.0K
YoY Change 2659.1% 82.77% 9.88%
SHAREHOLDERS EQUITY
Retained Earnings -$59.45M -$51.99M
YoY Change 26.6%
Common Stock $71.66M $49.67M
YoY Change -30.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.22M -$2.319M $18.17M
YoY Change
Total Liabilities & Shareholders Equity $36.77M $616.5K $19.06M
YoY Change 92.93% -98.1% -47.61%

Cashflow Statement

Concept 2017 Q3 2016 Q4 2016 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017Q3 plxp Accrued Severance Current
AccruedSeveranceCurrent
2409000
CY2016Q4 plxp Accrued Severance Current
AccruedSeveranceCurrent
CY2017Q3 plxp Built In Gains Tax Liability
BuiltInGainsTaxLiability
0
CY2017Q3 plxp Contract Manufacturing Deposits Current
ContractManufacturingDepositsCurrent
247050
CY2016Q4 plxp Contract Manufacturing Deposits Current
ContractManufacturingDepositsCurrent
CY2017Q3 plxp Convertible Notes Due To Related Parties Current
ConvertibleNotesDueToRelatedPartiesCurrent
CY2016Q4 plxp Convertible Notes Due To Related Parties Current
ConvertibleNotesDueToRelatedPartiesCurrent
480000
CY2017Q3 plxp Convertible Notes Excluding Related Parties Current
ConvertibleNotesExcludingRelatedPartiesCurrent
CY2016Q4 plxp Convertible Notes Excluding Related Parties Current
ConvertibleNotesExcludingRelatedPartiesCurrent
1297700
plxp Equity Offering Proceeds Allocated To Warrant Liability
EquityOfferingProceedsAllocatedToWarrantLiability
15876546
plxp Equity Offering Proceeds Allocated To Warrant Liability
EquityOfferingProceedsAllocatedToWarrantLiability
plxp Expenses Allocated To Warrant Liability
ExpensesAllocatedToWarrantLiability
1302995
plxp Expenses Allocated To Warrant Liability
ExpensesAllocatedToWarrantLiability
plxp Increase Decrease In Contract Manufacturing Deposits
IncreaseDecreaseInContractManufacturingDeposits
247050
plxp Increase Decrease In Contract Manufacturing Deposits
IncreaseDecreaseInContractManufacturingDeposits
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
173230
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
41961
plxp Increase Decrease In Interest Payable To Related Parties Net
IncreaseDecreaseInInterestPayableToRelatedPartiesNet
13747
plxp Increase Decrease In Interest Payable To Related Parties Net
IncreaseDecreaseInInterestPayableToRelatedPartiesNet
21049
plxp Increase Decrease In Security Deposit Liability
IncreaseDecreaseInSecurityDepositLiability
68415
plxp Increase Decrease In Security Deposit Liability
IncreaseDecreaseInSecurityDepositLiability
CY2017Q3 plxp Interest Payable Excluding Related Parties Current
InterestPayableExcludingRelatedPartiesCurrent
51563
CY2016Q4 plxp Interest Payable Excluding Related Parties Current
InterestPayableExcludingRelatedPartiesCurrent
64781
CY2017Q3 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
35759
CY2016Q4 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
CY2017Q3 plxp Interest Payable To Related Parties Current
InterestPayableToRelatedPartiesCurrent
CY2016Q4 plxp Interest Payable To Related Parties Current
InterestPayableToRelatedPartiesCurrent
30344
plxp Proceeds From Convertible Debt Excluding Related Parties
ProceedsFromConvertibleDebtExcludingRelatedParties
460000
plxp Proceeds From Convertible Debt Excluding Related Parties
ProceedsFromConvertibleDebtExcludingRelatedParties
1047700
plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
588300
plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
108300
plxp Proceeds From Convertible Debt Related Parties
ProceedsFromConvertibleDebtRelatedParties
455000
plxp Proceeds From Issuance Of Term Loan And Warrants Net Of Allocated Issuance Costs
ProceedsFromIssuanceOfTermLoanAndWarrantsNetOfAllocatedIssuanceCosts
7145584
plxp Proceeds From Issuance Of Term Loan And Warrants Net Of Allocated Issuance Costs
ProceedsFromIssuanceOfTermLoanAndWarrantsNetOfAllocatedIssuanceCosts
plxp Proceeds From Issuance Or Sale Of Equity Net Of Allocated Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfAllocatedIssuanceCosts
16698854
plxp Proceeds From Issuance Or Sale Of Equity Net Of Allocated Issuance Costs
ProceedsFromIssuanceOrSaleOfEquityNetOfAllocatedIssuanceCosts
dei Trading Symbol
TradingSymbol
plxp
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
plxp Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued In Connection With Merger Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedInConnectionWithMergerWeightedAverageExercisePrice
57.94
plxp Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued In Connection With Merger Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedInConnectionWithMergerWeightedAverageRemainingContractualTerm
plxp Sharebased Compensation Arrangement By Sharebased Payment Award Options Issued In Connection With Merger
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsIssuedInConnectionWithMerger
191963
plxp Term Loan Proceeds Allocated To Warrants
TermLoanProceedsAllocatedToWarrants
318398
plxp Term Loan Proceeds Allocated To Warrants
TermLoanProceedsAllocatedToWarrants
CY2017Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1045406
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
862995
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
71655397
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
49661802
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
318398
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1348310
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1803766
plxp Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
942040
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
571289
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3826302
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1040619
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2016Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2017Q3 us-gaap Assets
Assets
36771980
CY2016Q4 us-gaap Assets
Assets
616488
CY2017Q3 us-gaap Assets Current
AssetsCurrent
31455531
CY2016Q4 us-gaap Assets Current
AssetsCurrent
189854
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
15048883
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
285610
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11776427
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30438464
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59335
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91657
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187367
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
30379129
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
95710
CY2017Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
30400000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8719535
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4383433
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8719535
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4383433
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
8720
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
4383
CY2017Q3 us-gaap Customer Deposits Noncurrent
CustomerDepositsNoncurrent
68415
CY2016Q4 us-gaap Customer Deposits Noncurrent
CustomerDepositsNoncurrent
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2495630
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-920000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2017Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
200000
CY2017Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
920000
CY2017Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4064
CY2016Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4064
CY2017Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
56630
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12226
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3728
CY2017Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
13877668
CY2016Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.79
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1500000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y328D
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-252458
CY2016Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1998878
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3021290
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1041142
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8263019
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3343458
CY2017Q3 us-gaap Goodwill
Goodwill
2061022
CY2016Q4 us-gaap Goodwill
Goodwill
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-920000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3799500
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1082441
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8382574
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3451461
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10064
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
278150
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
51636
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1251
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
255806
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
116726
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
249037
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-13794
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2296429
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
us-gaap Interest Expense Debt
InterestExpenseDebt
891835
us-gaap Interest Expense Debt
InterestExpenseDebt
63010
CY2017Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
168272
CY2016Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
28969
us-gaap Interest Paid Net
InterestPaidNet
39531
us-gaap Interest Paid Net
InterestPaidNet
CY2017Q3 us-gaap Inventory Net
InventoryNet
372533
CY2016Q4 us-gaap Inventory Net
InventoryNet
116726
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
33600
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
166
us-gaap Investment Income Interest
InvestmentIncomeInterest
48082
us-gaap Investment Income Interest
InvestmentIncomeInterest
544
CY2017Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2017Q3 us-gaap Liabilities
Liabilities
24555954
CY2016Q4 us-gaap Liabilities
Liabilities
2935820
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36771980
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
616488
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3505969
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2735820
CY2017Q3 us-gaap Licenses Revenue
LicensesRevenue
CY2016Q3 us-gaap Licenses Revenue
LicensesRevenue
us-gaap Licenses Revenue
LicensesRevenue
us-gaap Licenses Revenue
LicensesRevenue
20000
CY2017Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6868143
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26412738
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1502700
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11577648
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7611257
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1406990
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3799500
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1082441
us-gaap Net Income Loss
NetIncomeLoss
-7462574
us-gaap Net Income Loss
NetIncomeLoss
-3451461
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
117786
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-28803
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1155125
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-62466
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
3979545
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
1053638
us-gaap Operating Expenses
OperatingExpenses
9975909
us-gaap Operating Expenses
OperatingExpenses
3408995
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3917286
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
43391
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
69516
CY2016Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
8957
us-gaap Paid In Kind Interest
PaidInKindInterest
664865
us-gaap Paid In Kind Interest
PaidInKindInterest
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
198779
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1053638
us-gaap Operating Income Loss
OperatingIncomeLoss
-9537699
us-gaap Operating Income Loss
OperatingIncomeLoss
-3388995
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
961240
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
150489
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
251751
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
244902
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
238243
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
75855
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
129879
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
336707
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4652
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2346000
CY2017Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
18200000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2000000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
902368
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
426634
CY2017Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
56713
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
5077
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
958255
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12496
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1712890
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65537
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59448091
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51985517
CY2017Q3 us-gaap Revenue From Grants
RevenueFromGrants
62259
CY2016Q3 us-gaap Revenue From Grants
RevenueFromGrants
us-gaap Revenue From Grants
RevenueFromGrants
438210
us-gaap Revenue From Grants
RevenueFromGrants
CY2017Q3 us-gaap Revenues
Revenues
62259
CY2016Q3 us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
438210
us-gaap Revenues
Revenues
20000
us-gaap Share Based Compensation
ShareBasedCompensation
1348310
us-gaap Share Based Compensation
ShareBasedCompensation
1803766
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
888124
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
238372
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9555
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
691374
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1121709
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.44
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.03
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.81
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y266D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y226D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7D
us-gaap Stock Issued1
StockIssued1
37500
us-gaap Stock Issued1
StockIssued1
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15048883
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3119538
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
37500
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2125303
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1348310
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
12216026
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-2319332
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt 7.5pt;text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> consolidated financial statements, estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, determining the fair value of tangible and intangible assets and liabilities acquired in business combinations, the fair value of warrant liabilities, share-based compensation, our allowance for inventory obsolescence, our allowance for doubtful accounts, contingent liabilities, the fair value and depreciable lives of long-lived assets, and deferred taxes and the associated valuation allowance. Actual results could differ from those estimates.</div></div></div></div></div>
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8704985
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4383433
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6447053
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4383433

Files In Submission

Name View Source Status
0001437749-17-018920-index-headers.html Edgar Link pending
0001437749-17-018920-index.html Edgar Link pending
0001437749-17-018920.txt Edgar Link pending
0001437749-17-018920-xbrl.zip Edgar Link pending
ex_97176.htm Edgar Link pending
ex_97177.htm Edgar Link pending
ex_97178.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
plxp-20170930.xml Edgar Link completed
plxp-20170930.xsd Edgar Link pending
plxp-20170930_cal.xml Edgar Link unprocessable
plxp-20170930_def.xml Edgar Link unprocessable
plxp-20170930_lab.xml Edgar Link unprocessable
plxp-20170930_pre.xml Edgar Link unprocessable
plxp20170930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending